| scholarly article | Q13442814 |
| P50 | author | Hal E. Broxmeyer | Q51754776 |
| Heather A. O'Leary | Q85323747 | ||
| Xuan Ou | Q104755112 | ||
| P2093 | author name string | Xuan Ou | |
| P2860 | cites work | Enhanced anti-HIV-1 activity and altered chemotactic potency of NH2-terminally processed macrophage-derived chemokine (MDC) imply an additional MDC receptor | Q24314848 |
| Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC | Q24329089 | ||
| Crystal structure of human dipeptidyl peptidase IV/CD26 in complex with a substrate analog | Q27640163 | ||
| Induced pluripotent stem cell lines derived from human somatic cells | Q27860597 | ||
| Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors | Q27860937 | ||
| Induction of pluripotent stem cells from adult human fibroblasts by defined factors | Q27860967 | ||
| Pharmacokinetics and pharmacodynamic effects of the oral DPP-4 inhibitor sitagliptin in middle-aged obese subjects | Q28252893 | ||
| Truncation of macrophage-derived chemokine by CD26/ dipeptidyl-peptidase IV beyond its predicted cleavage site affects chemotactic activity and CC chemokine receptor 4 interaction | Q28296438 | ||
| Transforming growth factor-beta stimulates vascular endothelial growth factor production by folliculostellate pituitary cells | Q28577476 | ||
| Osteoblastic cells regulate the haematopoietic stem cell niche | Q29615007 | ||
| Endothelial cells are essential for the self-renewal and repopulation of Notch-dependent hematopoietic stem cells | Q33837223 | ||
| Inhibition of pluripotential embryonic stem cell differentiation by purified polypeptides | Q34167801 | ||
| Isolation and characterization of exendin-4, an exendin-3 analogue, from Heloderma suspectum venom. Further evidence for an exendin receptor on dispersed acini from guinea pig pancreas | Q34234727 | ||
| Induced pluripotent stem cells: past, present, and future | Q34281955 | ||
| Osteoblasts support B-lymphocyte commitment and differentiation from hematopoietic stem cells. | Q50912728 | ||
| CD26/DPP-4 inhibition recruits regenerative stem cells via stromal cell-derived factor-1 and beneficially influences ischaemia-reperfusion injury in mouse lung transplantation. | Q53194242 | ||
| A prediction of DPP IV/CD26 domain structure from a physico-chemical investigation of dipeptidyl peptidase IV (CD26) from human seminal plasma | Q57975973 | ||
| Effect of Single Oral Doses of Sitagliptin, a Dipeptidyl Peptidase-4 Inhibitor, on Incretin and Plasma Glucose Levels after an Oral Glucose Tolerance Test in Patients with Type 2 Diabetes | Q58448492 | ||
| Both Subcutaneously and Intravenously Administered Glucagon-Like Peptide I Are Rapidly Degraded From the NH2-Terminus in Type II Diabetic Patients and in Healthy Subjects | Q58449089 | ||
| Stromal pleiotrophin regulates repopulation behavior of hematopoietic stem cells | Q64355556 | ||
| Dipeptidyl peptidase IV (DPP-IV) from pig kidney cleaves analogs of bovine growth hormone-releasing factor (bGRF) modified at position 2 with Ser, Thr or Val. Extended DPP-IV substrate specificity? | Q72227707 | ||
| CD26/DPP IV in experimental and clinical organ transplantation | Q73214416 | ||
| High potency antagonists of the pancreatic glucagon-like peptide-1 receptor | Q73596177 | ||
| Eotaxin (CCL11) induces in vivo angiogenic responses by human CCR3+ endothelial cells | Q73966728 | ||
| CD26/DPP IV-mediated modulation of acute rejection | Q74616820 | ||
| Cell surface peptidase CD26/DPPIV mediates G-CSF mobilization of mouse progenitor cells | Q78952597 | ||
| Basic FGF and suppression of BMP signaling sustain undifferentiated proliferation of human ES cells | Q34405302 | ||
| A new dipeptide naphthylamidase hydrolyzing glycyl-prolyl-beta-naphthylamide | Q34661843 | ||
| Engraftment and reconstitution of hematopoiesis is dependent on VEGFR2-mediated regeneration of sinusoidal endothelial cells | Q34957840 | ||
| Hematopoietic stem/progenitor cells, generation of induced pluripotent stem cells, and isolation of endothelial progenitors from 21- to 23.5-year cryopreserved cord blood | Q35001593 | ||
| Endothelial progenitor cell biology in disease and tissue regeneration | Q35069503 | ||
| Dipeptidyl-peptidase IV from bench to bedside: an update on structural properties, functions, and clinical aspects of the enzyme DPP IV. | Q35189265 | ||
| Endothelial and perivascular cells maintain haematopoietic stem cells | Q35724815 | ||
| Inhibition of CD26/DPP-IV enhances donor muscle cell engraftment and stimulates sustained donor cell proliferation | Q35822337 | ||
| CD26 inhibition enhances allogeneic donor-cell homing and engraftment after in utero hematopoietic-cell transplantation | Q35848800 | ||
| Touch of chemokines | Q36090029 | ||
| The HIF signaling pathway in osteoblasts directly modulates erythropoiesis through the production of EPO. | Q36127328 | ||
| Osteopontin is a hematopoietic stem cell niche component that negatively regulates stem cell pool size | Q36403763 | ||
| Erythropoietin: multiple targets, actions, and modifying influences for biological and clinical consideration | Q36603509 | ||
| Pleiotrophin induces transdifferentiation of monocytes into functional endothelial cells | Q36630308 | ||
| In vivo DPP-4 inhibition to enhance engraftment of single-unit cord blood transplants in adults with hematological malignancies | Q36715531 | ||
| Glypican-3-mediated inhibition of CD26 by TFPI: a novel mechanism in hematopoietic stem cell homing and maintenance. | Q36979528 | ||
| CD26 inhibition and hematopoiesis: a novel approach to enhance transplantation | Q36992247 | ||
| Dipeptidylpeptidase 4 negatively regulates colony-stimulating factor activity and stress hematopoiesis | Q37092134 | ||
| Migratory neighbors and distant invaders: tumor-associated niche cells | Q37100566 | ||
| Enhanced homing and engraftment of fresh but not ex vivo cultured murine marrow cells in submyeloablated hosts following CD26 inhibition by Diprotin A | Q37238470 | ||
| Dipeptidyl peptidase 4 as a therapeutic target in ischemia/reperfusion injury. | Q38031093 | ||
| Thrombin-cleaved osteopontin regulates hemopoietic stem and progenitor cell functions through interactions with alpha9beta1 and alpha4beta1 integrins. | Q38354428 | ||
| The isolated N-terminal domain of the glucagon-like peptide-1 (GLP-1) receptor binds exendin peptides with much higher affinity than GLP-1. | Q40678267 | ||
| The N-terminal X-X-Pro sequence of the HIV-1 Tat protein is important for the inhibition of dipeptidyl peptidase IV (DP IV/CD26) and the suppression of mitogen-induced proliferation of human T cells | Q41207427 | ||
| Exendin-4 is a high potency agonist and truncated exendin-(9-39)-amide an antagonist at the glucagon-like peptide 1-(7-36)-amide receptor of insulin-secreting beta-cells. | Q41527377 | ||
| FGF2 sustains NANOG and switches the outcome of BMP4-induced human embryonic stem cell differentiation | Q42031007 | ||
| Inhibition of insulin-like growth factor-1 (IGF-1) expression by prolonged transforming growth factor-β1 (TGF-β1) administration suppresses osteoblast differentiation | Q42036660 | ||
| Cardioprotective and vasodilatory actions of glucagon-like peptide 1 receptor are mediated through both glucagon-like peptide 1 receptor-dependent and -independent pathways | Q42165735 | ||
| MAPK regulation of IL-4/IL-13 receptors contributes to the synergistic increase in CCL11/eotaxin-1 in response to TGF-β1 and IL-13 in human airway fibroblasts | Q42187121 | ||
| Dipeptidyl-peptidase 4 and attractin expression is increased in circulating blood monocytes of obese human subjects | Q43144391 | ||
| The effect of organ-specific CD26/DPP IV enzymatic activity inhibitor-preconditioning on acute pulmonary allograft rejection. | Q43288509 | ||
| Posttranslational modifications affect the activity of the human monocyte chemotactic proteins MCP-1 and MCP-2: identification of MCP-2(6-76) as a natural chemokine inhibitor. | Q43471313 | ||
| CD26/dipeptidyl-peptidase IV down-regulates the eosinophil chemotactic potency, but not the anti-HIV activity of human eotaxin by affecting its interaction with CC chemokine receptor 3. | Q44111873 | ||
| Cell surface peptidase CD26/dipeptidylpeptidase IV regulates CXCL12/stromal cell-derived factor-1 alpha-mediated chemotaxis of human cord blood CD34+ progenitor cells | Q44241973 | ||
| Transforming growth factor‐β induces expression of vascular endothelial growth factor in human retinal pigment epithelial cells: Involvement of mitogen‐activated protein kinases | Q44623709 | ||
| Diprotin A infusion into nonobese diabetic/severe combined immunodeficiency mice markedly enhances engraftment of human mobilized CD34+ peripheral blood cells | Q45869269 | ||
| Inhibition of CD26 peptidase activity significantly improves engraftment of retrovirally transduced hematopoietic progenitors | Q45889148 | ||
| SDF-1/CXCL12 enhances survival and chemotaxis of murine embryonic stem cells and production of primitive and definitive hematopoietic progenitor cells | Q46740027 | ||
| Alkaline phosphatase and dipeptidylpeptidase IV staining of tissue components of skeletal muscle: a comparative study | Q46808310 | ||
| Cysteine and serine proteases of synovial tissue in rheumatoid arthritis and osteoarthritis | Q46929679 | ||
| Parathyroid hormone is a DPP-IV inhibitor and increases SDF-1-driven homing of CXCR4(+) stem cells into the ischaemic heart. | Q50528333 | ||
| CD26 is essential for normal G-CSF–induced progenitor cell mobilization as determined by CD26−/− mice | Q79223095 | ||
| TGF-beta1-mediated control of central nervous system inflammation and autoimmunity through the inhibitory receptor CD26 | Q79984998 | ||
| Modulation of hematopoietic stem cell homing and engraftment by CD26 | Q80450248 | ||
| Inhibition of CD26 in human cord blood CD34+ cells enhances their engraftment of nonobese diabetic/severe combined immunodeficiency mice | Q80566191 | ||
| CD26 inhibition on CD34+ or lineage- human umbilical cord blood donor hematopoietic stem cells/hematopoietic progenitor cells improves long-term engraftment into NOD/SCID/Beta2null immunodeficient mice | Q80566195 | ||
| In active chronic rheumatoid arthritis, dipeptidyl peptidase IV density is increased on monocytes and CD4(+) T lymphocytes | Q81239095 | ||
| Osteopontin, a key component of the hematopoietic stem cell niche and regulator of primitive hematopoietic progenitor cells | Q81676385 | ||
| Will iPS cells enhance therapeutic applicability of cord blood cells and banking? | Q82516273 | ||
| Association between pharmacodynamic biomarkers and clinical events in the early phase after kidney transplantation: a single-center pilot study | Q83942824 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 161-169 | |
| P577 | publication date | 2013-05-01 | |
| P1433 | published in | Blood | Q885070 |
| P1476 | title | Implications of DPP4 modification of proteins that regulate stem/progenitor and more mature cell types | |
| P478 | volume | 122 |
| Q91692081 | Alarming eosinophils to combat tumors |
| Q37443125 | Background and future considerations for human cord blood hematopoietic cell transplantation, including economic concerns |
| Q40277083 | Blastomyces dermatitidis serine protease dipeptidyl peptidase IVA (DppIVA) cleaves ELR+ CXC chemokines altering their effects on neutrophils. |
| Q38690194 | CD26/dipeptidylpeptidase IV-chemokine interactions: double-edged regulation of inflammation and tumor biology |
| Q42332008 | Cancer stem cell surface markers on normal stem cells |
| Q38199984 | Cardiovascular actions of GLP-1 and incretin-based pharmacotherapy. |
| Q47406797 | Cell intrinsic characteristics of human cord blood naïve CD4T cells |
| Q41686499 | Circulating dipeptidyl peptidase-4 activity correlates with measures of hepatocyte apoptosis and fibrosis in non-alcoholic fatty liver disease in type 2 diabetes mellitus and obesity: A dual cohort cross-sectional study |
| Q38111687 | Concise review: role of DEK in stem/progenitor cell biology |
| Q27012935 | Counteracting the enzymatic activity of dipeptidylpeptidase 4 for potential therapeutic advantage, with an emphasis on cord blood transplantation |
| Q42380920 | DPP4 truncated GM-CSF and IL-3 manifest distinct receptor-binding and regulatory functions compared with their full-length forms. |
| Q101166451 | DPP4+ exosomes in AML patients' plasma suppress proliferation of hematopoietic progenitor cells |
| Q64090961 | Definition of a cell surface signature for human cardiac progenitor cells after comprehensive comparative transcriptomic and proteomic characterization |
| Q95262759 | Diabetes and COVID-19 |
| Q90233364 | Dipeptidyl Peptidase 4 Inhibitors Reduce Hepatocellular Carcinoma by Activating Lymphocyte Chemotaxis in Mice |
| Q37067760 | Dipeptidyl Peptidase-4 Inhibitor Increases Vascular Leakage in Retina through VE-cadherin Phosphorylation |
| Q89729129 | Dipeptidyl peptidase 4 inhibitors and their potential immune modulatory functions |
| Q38416814 | Dipeptidyl peptidase-4 inhibitors and the risk of community-acquired pneumonia in patients with type 2 diabetes. |
| Q38215452 | Dipeptidyl peptidase-4 inhibitors can minimize the hypoglycaemic burden and enhance safety in elderly people with diabetes |
| Q38863969 | Dipeptidylpeptidase 4 inhibition enhances lymphocyte trafficking, improving both naturally occurring tumor immunity and immunotherapy |
| Q41851708 | Dipeptidylpeptidase-IV activity and expression reveal decreased damage to the intrahepatic biliary tree in fatty livers submitted to subnormothermic machine-perfusion respect to conventional cold storage |
| Q89231476 | Enhancement of stem cell engraftment on a WHIM |
| Q36984624 | Enhancing the efficacy of engraftment of cord blood for hematopoietic cell transplantation |
| Q51155176 | Enzyme-Histochemistry Technique for Visualizing the Dipeptidyl-Peptidase IV (DPP-IV) Activity in the Liver Biliary Tree. |
| Q47970956 | Erythropoietin in umbilical cord blood transplantation: defining the role and implications |
| Q36198586 | Fully Synthetic Granulocyte Colony-Stimulating Factor Enabled by Isonitrile-Mediated Coupling of Large, Side-Chain-Unprotected Peptides |
| Q40774687 | Fungal Mimicry of a Mammalian Aminopeptidase Disables Innate Immunity and Promotes Pathogenicity |
| Q54114587 | Hippo Signaling Plays an Essential Role in Cell State Transitions during Cardiac Fibroblast Development. |
| Q47830728 | Identification and characterization of secreted factors that are upregulated during somatic cell reprogramming. |
| Q99555339 | Identification of human CD4+ T cell populations with distinct antitumor activity |
| Q36406888 | Increased Proportion of Hematopoietic Stem and Progenitor Cell Population in Cord Blood of Neonates Born to Mothers with Gestational Diabetes Mellitus |
| Q41844813 | Inhibiting HDAC for human hematopoietic stem cell expansion |
| Q39804606 | Inhibition of DPP4/CD26 and dmPGE₂ treatment enhances engraftment of mouse bone marrow hematopoietic stem cells |
| Q41237048 | Inhibition of dipeptidyl peptidase-4 ameliorates cardiac ischemia and systolic dysfunction by up-regulating the FGF-2/EGR-1 pathway. |
| Q36560920 | Inter-tissue coexpression network analysis reveals DPP4 as an important gene in heart to blood communication |
| Q36174962 | Mechanism of Fibronectin Binding to Human Trabecular Meshwork Exosomes and Its Modulation by Dexamethasone. |
| Q34046207 | Modelling the sitagliptin effect on dipeptidyl peptidase-4 activity in adults with haematological malignancies after umbilical cord blood haematopoietic cell transplantation |
| Q36806357 | Modulation of Hematopoietic Chemokine Effects In Vitro and In Vivo by DPP-4/CD26. |
| Q28545955 | Mucosal-associated invariant T cell is a potential marker to distinguish fibromyalgia syndrome from arthritis |
| Q46630381 | Neuropeptide Y regulates a vascular gateway for hematopoietic stem and progenitor cells |
| Q26824239 | Profile of saxagliptin in the treatment of type 2 diabetes: focus on Japanese patients |
| Q48570285 | Regulation of Dipeptidyl Peptidase IV in the Post-stroke Rat Brain and In Vitro Ischemia: Implications for Chemokine-Mediated Neural Progenitor Cell Migration and Angiogenesis. |
| Q38390381 | Role of the neutrophil chemorepellent soluble dipeptidyl peptidase IV in decreasing inflammation in a murine model of arthritis |
| Q92153146 | Secreted nuclear protein DEK regulates hematopoiesis through CXCR2 signaling |
| Q98289684 | Sitagliptin Mitigates Total Body Irradiation-Induced Hematopoietic Injury in Mice |
| Q94545219 | The Current and Future State of Vaccines, Antivirals and Gene Therapies Against Emerging Coronaviruses |
| Q38518265 | The importance of hypoxia and extra physiologic oxygen shock/stress for collection and processing of stem and progenitor cells to understand true physiology/pathology of these cells ex vivo. |
| Q47200021 | Therapy-Educated Mesenchymal Stem Cells Enrich for Tumor-Initiating Cells |
| Q39242429 | Tissue-Specific Functions of p53 During Kidney Development |
| Q92861814 | VIP Promotes Recruitment of Tregs to the Uterine-Placental Interface During the Peri-Implantation Period to Sustain a Tolerogenic Microenvironment |
| Q35228883 | p53 Enables metabolic fitness and self-renewal of nephron progenitor cells |
Search more.